5.63
-0.34
(-5.70%)
At close: 4:00:01 PM EDT
5.63
0.00
(0.00%)
After hours: 4:05:14 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
134,317
134,317
-124,824
-110,062
-104,551
Investing Cash Flow
-101,590
-101,590
15,557
32,627
-126,835
Financing Cash Flow
154,417
154,417
94,783
38,565
-3,435
End Cash Position
224,462
224,462
37,318
51,802
90,882
Interest Paid Supplemental Data
1,096
1,096
1,064
73
784
Capital Expenditure
-472
-472
-168
-626
-1,147
Issuance of Capital Stock
145,813
145,813
93,577
24,721
--
Issuance of Debt
--
--
--
10,000
--
Repayment of Debt
--
--
--
--
-7,250
Free Cash Flow
133,845
133,845
-124,992
-110,688
-105,698
12/31/2021 - 9/16/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SNDX Syndax Pharmaceuticals, Inc.
10.52
-8.68%
DAWN Day One Biopharmaceuticals, Inc.
6.76
-7.02%
REPL Replimune Group, Inc.
6.92
-5.34%
STOK Stoke Therapeutics, Inc.
6.52
+1.40%
JANX Janux Therapeutics, Inc.
26.87
+0.15%
ANAB AnaptysBio, Inc.
16.24
-3.91%
RVMD Revolution Medicines, Inc.
33.67
-4.13%
BCYC Bicycle Therapeutics plc
6.53
-5.09%
COGT Cogent Biosciences, Inc.
4.0200
-9.87%
CRNX Crinetics Pharmaceuticals, Inc.
26.85
-2.93%